Page last updated: 2024-12-11

bryostatin 2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bryostatin 2: semisynthetic cpd from Ectoprocta (Bryozoa); activates protein kinase C [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bryostatin 2 : A member of the class of bryostatins that is bryostatin 1 in which the acetoxy group has been replaced by a hydroxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6438131
CHEMBL ID4549458
CHEBI ID139177
MeSH IDM0154002

Synonyms (14)

Synonym
bryostatin 2
SMP1_000026
BCBCMAP01_000139
CHEBI:139177
7-o-deacetylbryostatin 1
(1s,3s,5z,7r,8e,11s,12s,13e,15s,17r,21r,23r,25s)-1,11,21,25-tetrahydroxy-17-[(1r)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.1(3,7).1(11,15)]nonacos-8-en-12-yl (2e,4e)-octa-2,4-
2,4-octadienoic acid, (1s,3s,5z,7r,8e,11s,12s,13e,15s,17r,21r,23r,25s)-1,11,21,25-tetrahydroxy-17-((1r)-1-hydroxyethyl)-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo(21.3.13,7.111,15)nonacos-8-en-12-yl e
bryostatin 1, 7-o-deacetyl-
nsc 339554
(1s,3s,5z,7r,8e,11s,12s,13e,15s,17r,21r,23r,25s)-1,11,21,25-tetrahydroxy-17-[(1r)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl-(2e,4e)-2,4-octadieno
[(1s,3s,5z,7r,8e,11s,12s,13e,15s,17r,21r,23r,25s)-1,11,21,25-tetrahydroxy-17-[(1r)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2e,4e)-octa-2,4-di
CHEMBL4549458
CS-0029290
HY-108603
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
protein kinase C agonistAn agonist that selectively binds to and activates a protein kinase C receptor
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
bryostatinsAny of the structurally related macrolide compounds originally found in the bryozoan Bugula neritina and related organisms.
cyclic hemiketalA hemiacetal having the structure R2C(OH)OR (R =/= H), derived from a ketone by formal addition of an alcohol to the carbonyl group. The term 'cyclic hemiketals', once abandoned by IUPAC, has been reinstated as a subclass of hemiacetals.
enoate esterAn alpha,beta-unsaturated carboxylic ester of general formula R(1)R(2)C=CR(3)-C(=O)OR(4) (R(4) =/= H) in which the ester C=O function is conjugated to a C=C double bond at the alpha,beta position.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
organic heterotetracyclic compound
secondary alcoholA secondary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has two other carbon atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1634643Cytotoxicity against African green monkey BGM cells assessed as reduction in cell viability after 5 days by MTS/PMS based microscopic analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death.
AID1634642Antiviral activity against Chikungunya virus Indian Ocean 899 infected in African green monkey BGM cells assessed as inhibition of virus-induced cytopathic effect after 5 days by MTS/PMS based microscopic analysis2016Journal of natural products, Apr-22, Volume: 79, Issue:4
Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (46.15)18.7374
1990's4 (30.77)18.2507
2000's1 (7.69)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.05 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]